CD274 and metastatic neoplasm: We have previously shown that PD-L1 blockade can have therapeutic effects in the EMT6-CDDP tumor model when treating both primary tumors and postsurgical metastatic disease in the neoadjuvant or adjuvant treatment settings35,36.